Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.9620
-0.0222 (-2.26%)
At close: Jan 23, 2026, 4:00 PM EST
1.010
+0.048 (4.99%)
After-hours: Jan 23, 2026, 6:50 PM EST
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $7.83 million as of January 23, 2026. Its market cap has decreased by -31.46% in one year.
Market Cap
7.83M
Enterprise Value
8.48M
1-Year Change
-31.46%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $7.83M, a decrease of -98.12%. That is a compound annual growth rate of -42.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 7.83M | -9.25% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 8.50M |
| BriaCell Therapeutics | 8.42M |
| Alzamend Neuro | 8.36M |
| Quoin Pharmaceuticals | 8.05M |
| Addex Therapeutics | 7.85M |
| Kiora Pharmaceuticals | 7.78M |
| Mustang Bio | 7.66M |
| GT Biopharma | 7.57M |